Prophylaxis of Cytomegalovirus Infection With Adoptive Cell Inmunotherapy

Abroad (travel likely)RecruitingPHASE2

Conditions

CMV

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Hospital Marques de Valdecilla, Santander, Spain
Contact: Study coordinator (enrique ocio)

Study leads

Galo Peralta Fernandez, MD
Study Director
Instituto de Investigación Marqués de Valdecilla

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

CMV-TCIP Directed Letermovir Prophylaxis After Allo-SCT

CMV · Allogeneic Stem Cell Transplantation

Abroad (travel likely)RecruitingPHASE2

Orange, United States

Evaluation of the Safety and Efficacy of LB-DTK-MV in Patients Diagnosed With Antiviral-Resistant CMV, BKV, or EBV Infection or Associated Diseases Following Anticancer Therapy or Allogeneic Hematopoietic Stem Cell Transplantation.

BKV Infection · EBV Infection · CMV Infection

Abroad (travel likely)RecruitingPHASE1, PHASE2

Seoul, South Korea

Antigen-specific Cytotoxic T Cells in the Treatment of Opportunistic Infections

Pathogen Infection · EBV Infection · CMV Infection

Abroad (travel likely)RecruitingPHASE1, PHASE2

Shenzhen, China

Study Evaluating the Efficacy and Safety of Artesunate

CMV Infection

Abroad (travel likely)RecruitingPHASE2

Boston, United States · Rochester, United States